EE200000389A - Ampitsiliini eelravimi estri lahuse puhastamise protsess - Google Patents

Ampitsiliini eelravimi estri lahuse puhastamise protsess

Info

Publication number
EE200000389A
EE200000389A EEP200000389A EEP200000389A EE200000389A EE 200000389 A EE200000389 A EE 200000389A EE P200000389 A EEP200000389 A EE P200000389A EE P200000389 A EEP200000389 A EE P200000389A EE 200000389 A EE200000389 A EE 200000389A
Authority
EE
Estonia
Prior art keywords
purification process
ester solution
solution purification
prodrug ester
ampicillin
Prior art date
Application number
EEP200000389A
Other languages
English (en)
Estonian (et)
Inventor
Federsel Hans-J�rgen
K�nberg Erik
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from SE9704868A external-priority patent/SE9704868D0/xx
Priority claimed from SE9800255A external-priority patent/SE9800255D0/xx
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Publication of EE200000389A publication Critical patent/EE200000389A/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D499/00Heterocyclic compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. penicillins, penems; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D499/04Preparation
    • C07D499/18Separation; Purification
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D499/00Heterocyclic compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. penicillins, penems; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
EEP200000389A 1997-12-22 1998-12-16 Ampitsiliini eelravimi estri lahuse puhastamise protsess EE200000389A (et)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
SE9704868A SE9704868D0 (sv) 1997-12-22 1997-12-22 New process
SE9800255A SE9800255D0 (sv) 1998-01-29 1998-01-29 New process
PCT/SE1998/002347 WO1999032493A1 (fr) 1997-12-22 1998-12-16 Procede de purification d'une solution contenant un ester bioprecurseur d'ampicilline

Publications (1)

Publication Number Publication Date
EE200000389A true EE200000389A (et) 2001-12-17

Family

ID=26663170

Family Applications (1)

Application Number Title Priority Date Filing Date
EEP200000389A EE200000389A (et) 1997-12-22 1998-12-16 Ampitsiliini eelravimi estri lahuse puhastamise protsess

Country Status (21)

Country Link
US (1) US6414141B1 (fr)
EP (1) EP1049702B1 (fr)
JP (1) JP2001526291A (fr)
KR (1) KR20010024788A (fr)
CN (1) CN1284959A (fr)
AR (1) AR014939A1 (fr)
AU (1) AU741292B2 (fr)
BR (1) BR9814388A (fr)
CA (1) CA2315082A1 (fr)
DZ (1) DZ2687A1 (fr)
EE (1) EE200000389A (fr)
EG (1) EG21726A (fr)
HU (1) HUP0100403A3 (fr)
IL (1) IL136879A0 (fr)
IS (1) IS5530A (fr)
MA (1) MA26578A1 (fr)
NO (1) NO20002988L (fr)
NZ (1) NZ505166A (fr)
TN (1) TNSN98228A1 (fr)
TR (1) TR200001858T2 (fr)
WO (1) WO1999032493A1 (fr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7463626B2 (en) * 2000-11-21 2008-12-09 Roy Subhash C Phase and frequency drift and jitter compensation in a distributed telecommunications switch
US20040215003A1 (en) * 2002-11-12 2004-10-28 Dobbins Thomas A. Method for purifying and separating soy isoflavones
CN102284192B (zh) * 2011-06-16 2013-06-12 北京科技大学 并、逆流耦合式连续反萃青霉素设备及工艺
KR20230056433A (ko) 2021-10-20 2023-04-27 현대자동차주식회사 전자기판용 보호코팅 조성물 및 이의 제조방법

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3905959A (en) * 1973-05-07 1975-09-16 Pfizer Process for the manufacture of crystalline anhydrous ampicillin
NZ189945A (en) 1978-04-01 1981-04-24 Beecham Group Ltd Ampicillin phthalidyl ester naphthalene 2-sulphonate also pharmaceutical compositions
IL67637A0 (en) * 1983-01-07 1983-05-15 Orvet Bv Preparation of 1'-ethoxycarbonyl-oxyethyl esters of penicillins and novel intermediates
IT1214587B (it) * 1986-12-23 1990-01-18 Giovanni Bonfanti Metodo per la produzione diprodotti cristallini puri.

Also Published As

Publication number Publication date
US6414141B1 (en) 2002-07-02
NO20002988D0 (no) 2000-06-09
KR20010024788A (ko) 2001-03-26
JP2001526291A (ja) 2001-12-18
NO20002988L (no) 2000-06-09
AU1990399A (en) 1999-07-12
EP1049702B1 (fr) 2003-03-19
BR9814388A (pt) 2000-10-10
NZ505166A (en) 2002-02-01
WO1999032493A1 (fr) 1999-07-01
HUP0100403A2 (hu) 2001-08-28
HUP0100403A3 (en) 2001-12-28
TR200001858T2 (tr) 2000-10-23
MA26578A1 (fr) 2004-12-20
TNSN98228A1 (fr) 2005-03-15
EG21726A (en) 2002-02-27
IS5530A (is) 2000-06-13
AU741292B2 (en) 2001-11-29
AR014939A1 (es) 2001-04-11
EP1049702A1 (fr) 2000-11-08
IL136879A0 (en) 2001-06-14
DZ2687A1 (fr) 2003-03-29
CA2315082A1 (fr) 1999-07-01
CN1284959A (zh) 2001-02-21

Similar Documents

Publication Publication Date Title
PT977733E (pt) Derivados de acido arilsulfonilamino-hidroxamico
DK1003720T3 (da) Aryloxyarylsulfonylaminohydroxamsyrederivater
PT966430E (pt) Compostos anti-inflamatorios
ID24425A (id) Produksi alkilaromatik
EE200000321A (et) Uudsed ühendid
ATE238984T1 (de) Sulfonylaminocarbonsäuren
FI974225A0 (fi) Optisk mottagare
DE69815367D1 (de) Flachdichtungsherstellung
DE59804331D1 (de) Desinfektionsverfahren
ID20359A (id) Produksi dekstran
DE69835765D1 (de) Plasma-Verfahren
ID20656A (id) Ko-produksi ester
FI974224A0 (fi) Optisk mottagare
NO20003079D0 (no) Polymerisasjon-oppstartningsprosess
ID20509A (id) Alat pembersihan kriogenik untuk menghasilkan oksigen bermacam kemurnian
ID22662A (id) Proses pemurnian kaprolaktam
EE200000389A (et) Ampitsiliini eelravimi estri lahuse puhastamise protsess
ID24327A (id) Produksi senyawa-senyawa avermektin
IT236150Y1 (it) Accessorio per cicli
EE200000239A (et) Uued metüleenbisfosfoonhappe derivaadid
DE69818160D1 (de) Optischer Kodierer
DE59804807D1 (de) Pi-komplex-verbindungen
FI974536A0 (fi) Optisk mottagare
DE69634196D1 (de) Punkt-zu-multipunkt-verbindungen
NO982200L (no) Produksjonsprosess